Genome & Company (KOSDAQ:314130)
2,965.00
-185.00 (-5.87%)
At close: Nov 16, 2026
Genome & Company Market Cap
Genome & Company has a market cap or net worth of 155.07 billion as of November 16, 2026. It is the 23,841st most valuable company in the world and the 929th biggest in South Korea. Its market cap has increased by 64.91% in one year.
Market Cap
155.07B
Enterprise Value
129.79B
Revenue
24.46B
Global Rank
Country Rank
#929 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 155.07B, an increase of 115.74%. That is a compound annual growth rate of 10.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 155.07B | -34.95% |
| Dec 30, 2025 | 238.38B | 179.77% |
| Dec 30, 2024 | 85.21B | -51.64% |
| Dec 28, 2023 | 176.21B | -28.34% |
| Dec 29, 2022 | 245.90B | -47.55% |
| Dec 30, 2021 | 468.83B | -55.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IMBiologics | 200.00B |
| IntoCell | 196.49B |
| HansBiomed | 179.12B |
| curacle co.,ltd. | 176.37B |
| Kangstem Biotech | 165.82B |
| NIBEC | 146.31B |
| Y-Biologics | 134.77B |
| ISU Abxis | 131.09B |